Intro to acute Leukaemia Flashcards
Difference b.w Acute myleoid leukaemia (AML) & Acute Leukaemia (AL)
AML is a subcategoy of myeloid neoplasms and AL
Classifications of AML w/ recurrent genetic abnormalities
- No previous treatment (chemo, radio)
- Detect specific genetic abnormality defines of AML
- NOT need >20% blast for dx
Classifications of AML NOS (not otherwise specified) w/ recurrent genetic abnormalities
- No previous therapy (chemo, radio)
- No recurrent genetic abnormalities
- No myeloidsyplasia
what’s minimal residual disease concept?
- small amounts of remaining neoplastic cells
Dx this? if you get:
- Positive cytochemical staining for sudan black B, myeloperoxidase
- immunophenotype hyper granular
- Acute promyelocytic leukaemia
- mature myeloid type
(if phenotype was microgranular = immature phenotype)
Pathophysiology of acute promyelocytic leukaemia (APL)
- t(15:17) [translocation of 15 & 17]
= fusion gene PML-RARalpha = acts as an altered reitnoic acid receptor
=> oncogenic signaling
=> inc undifferentiated promyelocytes
Distinguish the morphology of
- AML w/ min. diff.
- AML acute monoblastic & monocytic leukaemia
- Pure erythroif leukaemia
- medium size, HIgh N:C rati, 1-2 nucleoli, basophilic cytoplasm
- predominantly monoblast
Dx this? & further test
- medium size,
- HIgh N:C rati, 1-2 nucleoli,
- basophilic cytoplasm
Dx: AML w/ min. diff.
Tests
Cytochem.
Cytogenetics = on specific chromo abnormalitlies
Immunophenotype: HLA-DR+, CD13+
Dx this? & further test
predominantly monoblast, promyelocyte & monocytes
dx: AML acute monoblastic & monocytic leukaemia
- Cytogenetics: non-specific chromosome abnormalities
- Immunophenotype: CD13+, CD33+
- Cytochem: alpha-naphtyl acetate esterase strongly Positive
Dx this?
- medium size,
- HIgh N:C rati, 1-2 nucleoli,
- basophilic cytoplasm
- FINE CHROMATIN
Dx: Pure erythroid leukaemia
- Cytochemistry: positive for glycophorin A , PAS
- Immunophenotype HLA-DR-